Form D — Axiom Therapeutics Inc.
0001231919-26-001065 · filed Aug 25, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Technology filings
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Reported offering amount
- $12,287,219
- Reported amount sold
- $12,287,219
- Minimum investment
- $0
- Investors
- 31
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Axiom Therapeutics Inc.
- CIK
- 2147556
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 2093 PHILADELPHIA PIKE #1369
CLAYMONT, DE 19703 - Phone
- 513-874-5502
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ryan John Geiser · Executive OfficerClaymont, DE Find on LinkedIn ↗
-
Christopher Patrick Hamilton Haggard · Executive OfficerClaymont, DE Find on LinkedIn ↗
-
Sofia Dahoune · DirectorClaymont, DE Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗